WU Hong-yan, RONG Qian-qian, LI Hai-long, et al. Effect of Danggui Beimu Kushen Wan Medicated Serum on Inhibition of Gastric Cancer Cells SGC-7901[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(2): 137-141.
WU Hong-yan, RONG Qian-qian, LI Hai-long, et al. Effect of Danggui Beimu Kushen Wan Medicated Serum on Inhibition of Gastric Cancer Cells SGC-7901[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(2): 137-141. DOI: 10.13422/j.cnki.syfjx.2016020137.
Objective:To study the effect of Danggui Beimu Kushen Wan medicated serum on the inhibition of gastric cancer cells SGC-7901and its antineoplastic mechanisms. Method:The 120 Wistar rats were divided into Danggui Beimu Kushen Wan high dose group
middle dose group and low dose group (0.3
0.2
0.1 g·kg-1) and normal group
n=30 in each group
ig 2 times/d
continuous for 7 days to prepare drug serum. The rats whose gastric cancer cells SGC-7901 were treated by blank serum were used as blank group. In the experiment groups
SGC-7901 cells were treated by high dose
middle dose and low dose Danggui Beimu Kushen Wan medicated serum
and then RT-qPCR technique was used to detect the expression level of mRNA of cyclooxygenase-2(COX-2)
Bcl-associated X protein(Bax)
and phosphatase and tensin homolog deleted on chromosome ten(PTEN). Immunocytochemical technique was used to test the protein expression level of COX-2
Bax
and PTEN. Result:Compared with the normal group
high dose group decreased the expression of COX-2 mRNA in SGC-7901 cell by 68%
and increased the expression of Bax and PTEN mRNA by 99.7% and 85.6% respectively (P<0.05). Drug serum can reduce the positive expression rate of COX-2 for SGC-7901 cells
increase its average gray value. increase the positive expression rate of Bax and PTEN
rate and reduce the average gray value (P<0.05). Conclusion:Danggui Beimu Kushen Wan medicated serum could inhibit the expressions of Bax
PTEN and COX-2 at mRNA and protein level in SGC-7901 gastric cancer cells.